Literature DB >> 10861748

Prostatic intraepithelial neoplasia: animal models 2000.

D G Bostwick1, D Ramnani, J Qian.   

Abstract

Numerous animal models of preinvasive prostate cancer have been described in the past decade. Differences among models account for their variable applicability for answering specific research questions. The dog is the only known nonhuman spontaneous animal model of prostate cancer, but numerous transgenic and therapy-induced models have been generated in mice and rats. This report summarizes existing models of prostatic intraepithelial neoplasia and their relevance for the study of human prostate cancer. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861748     DOI: 10.1002/1097-0045(20000601)43:4<286::aid-pros8>3.0.co;2-0

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.

Authors:  Hung-Ming Lam; Holly M Nguyen; Eva Corey
Journal:  Methods Mol Biol       Date:  2018

2.  Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.

Authors:  Veda Diwadkar-Navsariwala; Gail S Prins; Steven M Swanson; Lynn A Birch; Vera H Ray; Samad Hedayat; Daniel L Lantvit; Alan M Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

3.  Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.

Authors:  Sarki A Abdulkadir; Jeffrey A Magee; Thomas J Peters; Zahid Kaleem; Cathy K Naughton; Peter A Humphrey; Jeffrey Milbrandt
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation.

Authors:  Alexandre Matheus Baesso Cavalca; Andressa Brandi; Ricardo Henrique Fonseca-Alves; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.